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Abstract 
Calcium oxalate nephrolithiasis in rats requires 
induction ofhyperoxaluria which results in increased uri-
nary calcium oxalate supersaturation. As a result of low 
to mild chronic hyperoxaluria, calcium oxalate crystals 
deposit first in the papillary collecting ducts. Crystal 
deposition in the kidneys is preceded by calcium oxalate 
crystalluria and starts with the retention of aggregated 
calcium oxalate crystals in the renal tubules . Retained 
crystals move from the tubules to the interstitium, and in 
the process, become anchored to the tubular basement 
membrane. Crystal aggregates present in the superficial 
peripheral collecting ducts of the renal papillae ulcerate 
through to the papillary surface and grow into the 
stones. 
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Introduction 
Urinary stone formation or urolithiasis is a common 
human urological disorder and has been recognized as a 
health problem since the beginning of recorded history . 
Many in vitro and in vivo models have been developed 
to understand the mechanisms involved in the formation 
of urinary stones and to ascertain the effects of various 
therapeutic agents and protocols on development and 
progression of the disease. Calcium oxalate stones are 
most common. As a result, calcium oxalate urolithiasis 
has been studied in greater detail. The rat is the most 
frequently used animal in many such studies and induc-
tion of hyperoxaluria is the most common means to pro-
mote calcium oxalate urolithiasis . Various approaches 
applied in this regard were reviewed in 1985 (Khan and 
Hackett, 1985), and therefore, will not be considered 
here . Only the information published since that review 
and the knowledge obtained by using the rat models will 
be discussed in this paper. Pathogenesis of urolithiasis 
involves crystal nucleation , growth, aggregation and re-
tention of crystals within the urinary system. A variety 
of modulator s control these processes by promoting, in-
hibiting or modifying them. The final event in stone 
formation is the evolution of retained crystals into uri-
nary stones, a process which has not yet been dealt with 
experimentally. 
Crystal Nucleation 
Rat models have provided a wealth of information 
about how and where crystals of calcium oxalate are 
formed in the kidneys. Like humans, there is no sponta-
neous production of urinary stones by normal rats . In-
duction of hyperoxaluria is essential. Thus, rat models 
are similar to the human condi tion because in humans 
too, hyperoxaluria is regarded as one of the most com-
mon causes of idiopathic calcium oxalate urolithiasis 
(Robertson and Peacock, 1985; Coe et al., 1992; Khan 
1992). In male Sprague-Dawley rats, acute hyperoxa-
luria or moderate to high grade chronic hyperoxaluria, 
the latter being a condition somewhat similar to primary 
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Figure 1. Calcium oxalate (CaOx) monohydrate crystals (C) present in the lumen of the renal proximal tubule of a 
male rat, 1 hour after sodium oxalate injection at the dose of 7 mg/ 100 g rat body weight. Bar = 5 µm. 
hyperoxaluria in humans, results in initial calcium 
oxalate crystal deposition in the proximal segments of 
the renal tubules, while a low grade chronic hyperoxalu-
ria, a condition probably similar to most hyperoxaluric 
stone formers, starts the deposition of crystals in the 
distal segments of the renal tubules (Khan, 1991). Obvi-
ously, in the first situation, urine becomes highly super-
saturated with respect to calcium oxalate much earlier in 
the nephron, while in the second, urine becomes highly 
supersaturated with respect to calcium oxalate when it 
reaches the collecting duct system . This may be one of 
the reasons that the renal papilla is the most common 
site of human urinary stone formation. 
Morphological studies have demonstrated that crys-
tals of calcium oxalate first appear in the renal tubular 
lumina (Fig. 1) (Khan et al., 1979, 1982). Crystals that 
are left behind are later found in the interstitium (Fig. 2) 
or the tubular epithelial cells (Khan et al., 1992a). 
These findings suggested that calcium oxalate crystals 
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are initially formed in the lumen of renal tubules from 
where most of them are flushed out with the urine. The 
rest of the crystals migrate to the interstitium. A recent 
study has provided further evidence for this migration 
from the tubular lumen to the interstitium (de Bruijn et 
al., 1994). Intra-tubular crysta ls were produced in rat 
kidneys by administering a crystal-inducing regimen 
which involved mixing ethylene glycol and ammonium 
chloride in the drinking water. After nine days of such 
treatment, the rats were given regular water and diet for 
the next four days to flush out the free luminal crystals. 
The rats were divided into two groups. Those of group 
1 were sacrificed at this time and their kidneys process-
ed for microscopic examina tion . Rats of group 2 were 
then given a sublithogenic challenge for 12 or 30 days. 
Light microscopic examination of plastic embedded sec-
tions of the kidneys from the first group of rats showed 
that crystals were present: (1) as aggregates blocking the 
tubular lumina; (2) attached to the epithelial cell surface; 
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Figure 2. Birefringent crystals of CaOx monohydrate 
(C) present in the renal papillary interstitium , 6 hours 
after sodium oxalate injection. Bar = 50 µ,m. 
and (3) between or under the epithelial cells. Even after 
30 days, kidneys of group 2 rats contained crystals, but 
these crystals were now present in the renal interstitium. 
These observations indicate that crystals retained inside 
the renal tubular lumina are overgrown by several epi-
thelial cells, and then, are pushed out of the tubules into 
the interstitium. 
Presence of crystals in the cells may either indicate 
endocytosis or their formation inside the cells (Boeve et 
al., 1993). When exposed to preformed crystals, cul-
tured epithelial and other types of cells have been shown 
to endocytose a variety of crystal types (Emmerson et 
al., 1990), including calcium oxalate (Lieske et al., 
1992; Lieske and Toback , 1993; Hackett et al., 1994). 
A similar phenomenon is possible during nephrolithiasis. 
In most of the animal model studies where the time 
course of crystal formation and retention in the kidneys 
is known, appearance of crystals within the epithelial 
cells happens after the crystals have already been seen 
inside the tubular lumina (Khan et al., 1992a). In many 
cases, intracellular crystals are observed after large crys-
talline deposits have already been deposited within the 
renal tubules. Crystal deposition within the renal tubules 
is invariably associated with cellular damage. Damage 
to the cell is initially indicated by distortion of the brush 
border membrane (Fig. 3), clubbing of the microvilli 
and formation of large blebs (Khan and Hackett, 1985; 
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Figure 3. Formation of blebs (b) and loss of brush bor-
der membrane (*) in the presence of CaOx monohydrate 
crystals (C) 1 hour after sodium oxalate injection. Bar = 
5 µ,m. 
Boeve et al., 1993) . Increased lipid peroxidation has 
also been demonstrated in the kidneys of nephrolithic 
rats (Rengaraju and Selvam, 1989; Ravichandran and 
Selvam , 1990). All these changes indicate membrane 
damage . Once the cell membrane is damaged , it can no 
longer maintain its homeostatic function ; as a result, 
calcium and other ions may freely move in and out, re-
sulting in an increased supersaturation within the con-
fines of the cells, and eventually, causing the formation 
of crystals within the cells. 
Rat studies of calcium oxalate urolithiasis demon-
strate that crystalluria and nephrolithiasis occur at an 
approximate relative supersaturation of 20 (Khan and 
Hackett, 1987a; Khan et al., 1992b), which is not high 
enough for homogeneous nucleation of calcium oxalate 
crystals (Finlayson, 1978). Thus, it is most likely that 
crystal nucleation in rat urine is heterogeneous. What 
biological or crystalline materials can act as the substrate 
for crystal nucleation in nephrolithiasis? It has been 
suggested that calcium phosphate crystals may act as nu-
cleators of calcium oxalate, since calcium phosphate is 
the most common crystal found in human urine and uri-
nary stones (Murphy and Pyrah, 1962; Wemess et al., 
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1981) and can cause nucleation of calcium oxalate in 
vitro from a metastable solution of calcium oxalate 
(Meyer et al., 1975). Our extensive studies of calcium 
oxalate nephrolithiasis in rats have failed to demonstrate 
any calcium phosphate in association with deposits of 
calcium oxalate in the kidneys. 
We tested the hypothesis that renal deposits of cal-
cium phosphate can provoke precipitation of calcium ox-
alate within the renal tubules (Khan and Glenton, 1995). 
We induced calcium phosphate renal deposits followed 
by mild hyperoxaluria. In one experiment, both male 
and female rats were first given a calcium phosphate-in-
ducing diet, the so-called AIN 76 diet, and then, put on 
a hyperoxaluria-inducing protocol involving mixing of 
ethylene glycol in the drinking water. Female rats re-
sponded to the calcium phosphate-inducing diet by gen-
erating calcium phosphate crystal deposits in renal tu-
bules at the cortico-medullary junction. Male rats re-
sponded to the hyperoxaluric challenge by producing cal-
cium oxalate crystals in the collecting ducts of the renal 
papillae. Small deposits of calcium oxalate were seen in 
kidneys of the female rats on hyperoxaluria-indu cing 
protocol. Male rats on calcium phosphate-inducing diet 
did not produce any calcific deposit s in their kidneys . 
In another experiment, a calcium phosphate-inducing diet 
and hyperoxa luric challenge were simultaneously deliv-
ered to female rats. This resulted in calcium phosphate 
and calcium oxalate crys talluria as well as nephrolithia-
sis, but calcium oxalate crystals were not observed in as-
sociation with calcium phosphate crys tals. Result s of 
these experiments suggest that calcium phosphate is not 
necessary for calcium oxalate nephrolithiasis. 
Then what is the heterogeneo us nucleator of calcium 
oxalate crystals? Urinary as well as renal calcium oxa-
late crystals induced in rats are almost always found as-
sociated with cellular degradation products, including 
their membranous components (Khan and Hackett, 
1985). Membranous cellular degradation products and 
their constituent lipids are an important part of the 
matrix of human urinary stones (Khan et al., 1988). 
Both the lipids isolated from human urinar y stones and 
the membrane vesicles obtained from renal proximal tu-
bular brush border have been shown to induce crystalli-
zation of calcium oxalate from a metastable solution 
(Khan et al., 1988, 1989, 1993). Moreover, thousand s 
of epithelial cells are released in the urine by mamma-
lian kidneys. Human kidney s release approximately 
70,000 cells/hour (Prescott, 1966). Thus , mammalian 
urine is replete with cellular degradation products which 
can nucleate calcium oxalate crystals and do not require 
any other type of heterogeneous nucleators. This abun-
dance of nucleators in the urine may be the reason why 
mammalian urine contains such a variety of crystalliza-
tion inhibitors (Robertson and Peacock, 1985; Coe et 
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al., 1992; Khan , 1992). 
Mammalian urine contains both inhibitors and pro-
moters of crystallization (Khan, 1992). In normal indi-
viduals , inhibitors may have the upper hand, but in stone 
formers , urine is either less inhibitory or becomes less 
inhibitory during stone forming episodes. Alternatively, 
the promotory potential of urine may increase by virtue 
of an increase in heterogeneous nucleators . We decided 
to test this hypothesis by increasing the membranous cel-
lular degradation products as heterogeneous nucleators 
in the urine (Hackett et al., 1990). Membranuria of re-
nal proximal tubular origin was induced by administra-
tion of gentamicin sulphate to male Sprague-Dawley 
rats. A low grade hyperoxaluria was produced by ethyl-
ene glycol administration. Hyperoxaluria or gentamicin 
treatment alone did not cause the formation of crystals 
in the urine, but simultaneous production of membranu-
ria and hyperoxaluria resulted in calcium oxalate crystal-
luria . Crystals were formed in association with the 
membranous substances in the urine. These observa-
tions were later confirmed when a higher grade hyper-
oxaluria in association with gentamicin-induced mem-
branuria resulted in 63 % of rats with calcium oxalate 
nephrolithiasis (Kumar et al., 1991). Hyperoxaluria 
alone induced nephrolithiasis in only 6 % of the treated 
rats. 
Sex Hormones and Nephrolithiasis 
Sex is a well known risk factor for the formation of 
urinary stones. Idiopathic calcific stone disease is two 
to three times more common in men than in women 
(Robertson and Peacock, 1985). Kidney stones found in 
men are normally calcium oxalate while those in females 
are usually calcium phosphate (Otnes, 1980). Reasons 
for these differenc es between sexes are still not clear. 
The lower rate of calcific nephrolithiasis in women is 
suggested by some to be a result of higher urinary ex-
cretion of citrate (Tiselius, 1985), and by others, an 
effect of lower urinary excretion of calcium and oxalate 
(Robertson et al., 1978). Finlayson (1974) postulated 
that lower testosterone levels might cause lower excre-
tion of oxalate and contribute to some of the protection 
against calcium oxalate stone formation in women . Re-
sults of studies involving rat models of nephrolithiasis 
have provided some explanation for this interesting 
phenomenon . 
Spontaneous deposition of calcium phosphate in the 
kidneys of rats on semi-purified diets, like AIN-76, has 
been reported by many investigators and the incidence of 
lesion formation is consistently higher in females than 
males (Geary and Cousins, 1969; Nguyen and Woodard, 
1980). Calcification starts intraluminally at the cortic-
o-medullary junction spreading into the medulla. Estro-
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gen, in addition to the dietary levels of calcium, phos-
phorus and magnesium has been determined to play a 
significant role in the development of this disease. 
Ovariectomy resulted in cessation of calcification, while 
replacement therapy with estrogen · following gonadec-
tomy resulted in calcium phosphate nephrolithiasis in 
both male and female rats (Geary and Cousins, 1969). 
Administration of 1 % ethylene glycol in drinking 
water for 4 weeks produced calcium oxalate nephrolithi-
asis in 3/13 males but 0/12 females (Lyon et al., 1966). 
Urinary acidification increased the incidence to 5/6 
males and 1/9 females. These observations demon-
strated an association between gender and urolithiasis but 
did not provide a justification for the phenomenon. In 
an attempt to determine the role of testosterone, 0.5 % 
ethylene glycol was used to induce calcium oxalate ne-
phrolithiasis in male and female, normal and gonadec-
tomized rats (Lee et al, 1992). Low level calcium oxa-
late crystal deposition was found in all rats but in normal 
males, 5/7 produced kidney stones and 4/7 had massive 
calcium oxalate crystal deposition. Only 1/7 castrated 
males produced kidney stones and none of them had 
massive calcium oxalate crystal deposition in their kid-
neys . None of the female rats, normal or castrated, pro-
duced any kidney stones or massive crystal deposition in 
their kidneys. As a result of the study , it was suggested 
that testosterone plays a determina nt role in the patho-
genesis of urolithia sis. 
As indicated earlier, we recently studied calcium 
phosphate and calcium oxalate nephrolithiasis in both 
male and female rats (Khan and Glenton, 1995). Calci-
um phosphate deposition was induced by feeding a semi-
purified diet, the AIN-76, and calcium oxalate, by ad-
ministration of ethylene glycol in association with urina-
ry acidification. Rats of the same strain and same age 
and similar weight were used. Calcium phosphate depo-
sition was confined to the cortico-medullary junction as 
has been demons trated by other investigators and calci-
um oxalate was mostly localized to renal papillae and 
fomices. All rats of both sexes receiving ethylene 
glycol had calcium oxalate deposits in their kidneys but 
only male rats had massive crystal deposition and 
crystals at the renal papillary tips . Only female rats 
produced calcium phosphat e deposits on the AIN diet. 
These results are similar to those of earlier investigators 
discussed above. But both male and female rats had 
similar relative supersaturations for both calcium oxalate 
and calcium phosphate. Lee et al . (1992) have also 
shown that gonadectomy did not significantly influence 
the urinary biochemistry. Then, why did male and fe-
male rats behave differently when it came to nephro-
lithiasis? Nephrolithiasis involves crystal formation and 
retention (Finlayson and Reid, 1978). The latter can be 
facilitated by crystal aggregation (Kok and Khan, 1994). 
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Perhaps , there are some differences in urinary inhibitors 
of crystal aggregation between males and females. 
Crystal Growth and Aggregation 
It is generally agreed that stone forming humans ex-
crete larger and more aggregated crystals than the non-
stone formers (Robertson et al., 1971). No specific 
study has been done to examine crystal growth and ag-
gregation in rat models of urolithiasis and no quantitative 
data are available. However, morphological examination 
of crystals produced by nephrolithic rats has shown that 
first-form ed crystals are generally small and single, and 
easily pass through the nephron and clear the kidneys. 
In later stages of the disease, both excreted crystals, as 
well as those retained inside the nephron , are larger and 
aggregated (Khan and Hackett, 1991). 
Crystallization Modulators 
There are two major categories of crystallization 
modulators present in human urine (Robertson and 
Peacock , 1985; Khan, 1992) . One consists of citrate 
(Meyer and Smith, 1975; Antinozzi et al., 1992) pyro -
phosphate (F!eisch and Bisaz, 1962) and magnesium 
(Desmars and Tawashi, 1973) and the other of urinary 
macromolecules, Tamm-Horsfall protein (THP) (Hess, 
1991), osteopontin (OP, uropontin) (Shiraga et al . , 
1992), nephrocalcin (NC) (Nakagawa et al., 1984), 
uronic acid rich protein (UAP) ( Atmani et al., 1993; 
Atmani and Khan, 1995) , and inter-a-trypsin inhibitor 
(Sorensen et al. , 1990). Magnesium and citrate form 
soluble complexes with oxalate and calcium, respectively 
(Robertson and Peacock, 1985). Citrate also binds to 
the surface of calcium oxalate crystals, interferes with 
their growth and modifies their morphology (Antinozzi 
et al. , 1992; Shirane and Kagawa 1993). Magnesium 
has been extensively studied in animal models of calcium 
oxalate urolithiasis and it has been shown that magnesi-
um administration in the form of alkalinizing salts causes 
a decrease in calcium oxalate crystal deposition in the 
kidneys of hyperoxaluri c rats (Ogawa et al., 1990; Su et 
al., 1991; Khan et al., 1992b). Magnesium reduces the 
amount of oxalate excreted in the urine, thereby result-
ing in a reduced urinary calcium oxalate relative super-
saturation . 
Much of the information about THP , OP (uropon-
tin), NC, and UAP, including their normal renal distri-
bution has been obtained from studies of rat kidneys by 
using immunohistological techniques and in situ hybridi -
zation. THP is localized to the thick ascending limb of 
the loop of Henle (Bachmann et al., 1990), NC to the 
proximal tubule as well as thick ascending limb of the 
loop of Henle (Nakagawa et al., 1984; Srivongs et al., 
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1989), while OP to the collecting duct system (Lopez et 
al., 1993). However, all the tubules do not stain for the 
OP. Uronic acid rich protein has also been isolated 
from both rat and human urine (Atmani et al., 1993; 
Atmani and Khan, 1995). Most of the information about 
their roles in calcium oxalate crystallization comes from 
in vitro studies, mainly performed in inorganic solutions. 
OP, NC and UAP are potent inhibitors of calcium oxa-
late crystallization while the role of THP is controversial 
(Hess, 1991). Depending upon pH, glycosylation, self-
aggregation and concentration of other ions in the solu-
tion, THP can be a promotor or inhibitor of crystalliza-
tion . Results of one study carried out in human urine 
demonstrated that the effect of THP on calcium oxalate 
crystallization depends upon the methodology used to 
asses it (Grover et al., 1990). THP promoted calcium 
oxalate crystallization induced by evaporation of urine 
but inhibited growth and aggregaJioll_ of calcium oxalate 
crystals induced by addition of an oxalate load . 
Recently, the distribution of THP and OP was stud-
ied in rat kidneys with calcium oxalate nephrolithiasis 
(Gokhale et al., 1994 and unpublished personal observa-
tions). Mild chronic hyperoxaluria was induced in male 
Sprague-Dawley rats, which resulted in calcium oxalate 
crystal deposition in renal papillae . Kidney sections 
were stained for both THP and OP using polyclonal anti-
bodies . Crystal deposit s were surrounded by THP as 
well as OP. Epithelial cells around the crystal deposits 
were also positive for THP as well as OP. Both THP 
and OP are generally absent from the papillary ducts, 
their lurnina as well as the epithelial cells. Presence of 
THP and OP in association with the crystals may be ac-
cidental due to the tubular blockage by the crystals or 
indicate THP and OP involvement in crystal deposition . 
Transmission electron microscopic examination of the 
demineralized calcium oxalate crystals stained for OP 
demonstrated the incorporation of the protein into the 
organic matrix of crystals (McKee and Khan, 1994). 
This indicates a much closer affiliation between calcium 
oxalate crystal formation and OP. 
Ryall and associates isolated a matrix protein from 
calcium oxalate crystals newly generated in the fresh 
whole normal human urine (Doyle et al., 1991). They 
aptly named the protein, crystal matrix protein or CMP. 
CMP was found to be a potent inhibitor of calcium oxa-
late crystallization and was localized to the distal convo-
luted tubule and the thick ascending limb of the loop of 
Henle using a polyclonal antibody raised against human 
CMP (Stapleton et al., 1993b). Recently, 81.8% se-
quence identity was revealed between 11 N-terrninal 
amino acids of CMP and N-terminus of human pro-
thrombin . The relationship between human CMP and 
prothrombin was confirmed by demonstrating the reac-
tion between an antibody to human prothrombin and 
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CMP western blots (Stapleton et al., 1993a). CMP or 
prothrombin has not yet been studied in human stone 
formers or animal models of nephrolithiasis. 
Crystal Retention 
Crystal retention is indispensable to the development 
of kidney stones, and rat models have provided valuable 
information about the mechanisms involved in this proc-
ess. Crystal size can play an important role, and thus, 
any mechanism , that can result in mass accretion by the 
crystal deposits , can regulate the process of crystal re-
tention. Taking into account the rate of crystal growth, 
dimension of the renal tubules and the time it takes the 
urine to pass through the nephron , Finlayson and Reid 
(1978) concluded that crystals of calcium oxalate can not 
grow fast enough to be retained within the renal tubules 
because of their size alone. They concluded that it is 
necessary for the crystals to attach to the tubular epithe-
lium for retention within the kidneys. We recently re-
visited this issue, calculated the rate of mass accretion 
by crystal deposits taking into account the process of 
crystal aggregation, and found that crystal aggregates 
can become large enough to block the renal tubules, and 
thus, be retained solely because of the aggregate size 
(Kok and Khan , 1994). Animal studies have demon-
strated that as the disease progresses, more aggregated 
crystals are formed and aggregates are generally large 
enough to be retained without attachment to the renal tu-
bules. Often , the crystals deposit at sites where the lu-
minal diameter of the tubules narrow s, e.g., at the prox-
imal tubule/loop of Henle junction or at the papillary 
base where renal tubules bend (Khan and Hackett, 
1991). It is also interesting to point out that the open-
ings of the ducts of Bellini into the renal pelvis are not 
circular, but slit-like, and are much narrower than the 
luminal diameter of the ducts of Bellini . 
Crystals have also been found to be retained inside 
the tubules by attachment to the renal epithelial cell sur-
face (Fig. 4) as well as epithelial basement membrane 
(Khan et al., 1982; Khan and Hackett, 1991). It has 
also been demonstrated that calcium oxalate crystals ad-
here to the surface of injured rat renal papillary epithe-
lial cells in primary culture (Riese et al., 1992a,b). Cal-
cium oxalate crystal deposition in the renal tubules is as-
sociated with injury to the epithelium which often results 
in detachment of the cells from its basement membrane. 
In an experiment where acute hyperoxaluria was induced 
by intraperitoneal injection of sodium oxalate, crystal 
attachment to the basement membrane was seen hours 
after the challenge (Khan et al. , 1982) suggesting that, 
most probably, it is not the result of crystal nucleation 
by the basement membrane constituents but rather a 
phenomenon of crystal attachment. As discussed earlier, 
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Figure 4 (at left). Crystals of CaOx monohydrate (C) are attached to the brush border (B) of a renal proximal tubule 
by tangling with microvillous projections (arrowheads) . Bar = 5 ~m. 
Figure 5 (at right). Agglomerate of CaOx monohydrate crystals present in the bladder urine of a rat receiving 0. 75 % 
ethylene glycol in drinking water. Crystals are associated with an amorphous matrix material. When similar crystals 
were examined by transmission electron microscopy, the amorphous substance surrounding the crystals was identified 
as cellular degradation products. Bar = 5 ~m. 
crystals retained inside the tubular lumen can migrate to 
the interstitium. 
It has been argued that crystals actually form in the 
renal papillary interstitium (Hautmann and Osswald, 
1983), since most of the oxalate , particularly that in the 
renal papilla, is present in the interstitium, and the papil-
la has the highest concentration of calcium and oxalate 
within the kidney (Wright and Hodgkinson, 1972). If 
crystals have already formed in the interstitium then re-
tention will not be an issue. However, all morphologi-
cal studies of nephrolithiasis, some of them discussed 
above, have clearly shown that initial crystal formation 
starts in the tubular lumen. Interstitial crystals are seen 
much later during nephrolithiasis. In addition, once 
crystals move into the interstitium, they do not seem to 
grow. They actually seem to disappear (Khan et al., 
1992a). 
Crystals are also seen inside the epithelial cells and 
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this could indicate another means of retention, however, 
such cells normally appear damaged and may be slough-
ed off and take the crystals with them. It has, however, 
recently been shown that renal epithelial cells in culture 
can function normally, even multiply , after endocytosing 
the crystals (Lieske et al. , 1992; Lieske and Toback, 
1993). Thus, healthy cells may also contain crystals, 
but these crystals will not be available for further growth 
and may not be available for stone formation. More-
over, such endocytosis may represent a defensive mech-
anism against injury-causing calcium oxalate crystals. 
It has been proposed that crystals of calcium oxalate 
may form subepithelially on the renal papillary surface, 
resulting in spontaneous retention (Chandhoke and 
Hruska, 1993). The crystals then ulcerate to the surface 
where they are exposed to the pelvic urine and provide 
a nidus for the development of urinary stones. The 
papillary surface is a common site for the formation of 
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urinary stones in humans. 
Renal Injury and Nephrolithiasis 
Human stone forming patients generally display ab-
normal urinary chemistry and some form of functional 
or structural tubular abnormalities and/or tubular damage 
(Jaeger et al., 1986). This aspect of kidney stone for-
mation bas been extensively studied in rat models (Khan 
et al., 1979, 1982, 1992a; Khan and Hackett, 1985; 
Kumar et al., 1991). It has been found that calcium ox-
alate crystallization results in both covert and overt dam-
age to the renal tubular epithelium. The extent of the 
damage appears to be related to the magnitude of hyper-
oxaluria. A low grade hyperoxaluria, which caused no 
crystal deposition in the kidneys, still resulted in damage 
to the proximal tubular epithelial cells as evidenced by 
increased enzymuria (Khan et al., 1989). This is impor-
tant information, since most human stone formers have 
only a mild hyperoxaluria and also display enzymuria of 
proximal tubular origin (Baggio et al., 1983). In addi-
tion, recent studies using cultured epithelial cells have 
also shown that the oxalate ion itself can be damaging to 
the cells (Hackett et al . , 1994). It has airead y been es-
tablished that cells exposed to many types of crystals, in-
cluding calcium oxalate, are invariably injured. Injury 
results in cell sloughing and membranuria. Both aggre-
gated, as well as single crystals of calcium oxalate pre-
sent in the kidneys or the urine (Fig. 5), are always seen 
associated with cellular membranes . Sloughed cellular 
membranes may become involved in both crystal nuclea-
tion and aggregation (Khan and Hackett , 1987b). Cell 
sloughing also exposes the basement membrane which 
can be a likely site for crystal attachment and retention 
and thus initiation of stone formation. 
Many macromolecules involved in calcium oxalate 
crystallization are produced by renal tubular epithelial 
cells, particularly the epithelium lining the proximal 
tubules and the loop of Henle (Coe et al., 1991). Any 
damage to these cells may interfere with the production 
of crystallization inhibitory macromolecules. Urine of 
rats treated with gentamicin sulphate, which is specifi-
cally toxic to the proximal tubular epithelial cells of the 
kidneys, has already been shown less inhibitory to cal-
cium oxalate crystallization processes (Finlayson et al., 
1989). 
Development of Urinary Stones 
Crystal retention is essential for the development of 
stone disease, but how do the retained crystals develop 
into kidney stones? No studies, animal or otherwise, 
have been performed to specifically study the transition 
from retained crystals to kidney stones. However, a 
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number of observations have been made that can assist 
us in developing a probable scenario . It has been dem-
onstrated that induction of acute hyperoxaluria results in 
the development of an instantaneous calcium oxalate 
nephrolithiasis in male rats (Khan et al., 1979, 1992a). 
Crystals are seen in the kidneys up to seven days after 
the challenge. They are first seen in the tubular lumen 
and later, by day seven, in the interstitium as well as 
inside the cells. Thus, crystals move from the tubular 
lumen to the interstitium. Another, more recent study 
of chronic hyperoxaluria in male rats has similarly dem-
onstrated crystal movement from the lumen to the inter-
stitium (de Bruijn et al., 1994). Both studies have also 
shown that the number of retained crystals appears to 
decrease with time. In addition, we have recently ob-
served interstitial crystals surrounded by cells which are 
generally involved in the inflammatory processes 
(unpublished personal observations). 
Crystals are retained at many sites in the kidneys, 
the most common being the cortico-medullary junction 
(Khan and Hackett, 1991). Kidney stones, however, de-
velop on papillary surfaces (Figs. 6a and 6b) in the renal 
calyx and fomix. What are the reasons for stone devel-
opment in association with the renal papillae and at these 
particular sites? One reason may be that the renal papil-
la has the highest concentration of calcium and oxalate 
relative to the cortex and medulla (Wright and Hodgkin-
son, 1972; Hautmann and Osswald, 1983). Other rea-
sons, as discussed in earlier paragraphs, may be related 
to the anatomy and histology of the papilla (Fig. 6c) 
which make it possible for the crystals to be retained at 
these sites. It has already been discussed above that, 
with passage of time, luminal crystals move out of the 
tubule and into the interstitium. Apparently, the crystals 
retained in peripheral collecting ducts and those retained 
in more central collecting ducts follow different paths . 
The crystals retained in more central ducts move into the 
renal interstitium (Fig. 6a) towards the interior of the 
kidney. Once in the interstitium, they are not exposed 
to the urine and hence to the urinary calcium and oxalate 
ions. Thus, they are unable to grow . Moreover , now 
they may be subjected to the body's inflammatory proc-
ess and be finally destroyed. On the other hand, when 
crystals are retained in the peripheral collecting ducts, or 
in ducts at the papillary tips or base, they can ulcerate to 
the papillary surface (Figs. 6a and 6b). Once out on the 
surface, they are continuously bathed in pelvic urine and 
urinary calcium and oxalate ions, and can grow indefi-
nitely. Thus, it is clear that for the development of 
kidney stones, not only must the crystals be retained in 
the kidneys, but they should be located in the tubules 
from where they can ulcerate to the surface, be exposed 
to urine, and be available for further growth. 
Calcium oxalate nephrolithiasis 
Figure 6. (a). Light micrograph of a median section through the renal papilla of a rat receiving 0. 75 % ethylene glycol 
in drinking water. Papillary tip and sides are covered with CaOx monohydrate crystal deposits (C). Section shows an 
epithelial covering (arrows) over the deposits indicating that crystals originated inside the papilla and near the surface. 
Some crystals, present in the papillary interior, are located in the interstitium (arrowhead). Bar = 500 !,till, (b). 
Scanning electron micrograph of the papilla from a rat with similar treatment as rat in Figure 6a. A large CaOx stone 
(C) is present at the papillary tip. Bar = 1000 1-tm, (c) . Papillary tip of a normal rat on normal water and diet show-
ing openings of the ducts of Bellini (arrows). Even though the openings are large lengthwise, they are slit-like with 
narrow width which will impede the movement of big crystal aggregates. Bar = 100 !,(ID. 
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Discussion with Reviewers 
R.P. Holmes: Is there any evidence that crystals 
retained beneath the epithelium in collecting ducts or 
papillae can "ulcerate" or otherwise move to the lumen 
surface or are you putting this forward as a hypothesis? 
Author: From the evidence presented, I am concluding 
that crystals are ulcerating out of the tubules onto the 
papillary surface . 
R.P. Holmes: You have mentioned three possible ways 
for crystals retained by the kidney to act as nidus for 
stone formation: (1) ductal occlusion by crystals, (2) at-
tachment to "injured" epithelium, and (3) "ulceration" of 
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subepithelial crystals . Do you believe that any one 
mechanism predominates or that all three may occur in 
stone formation? 
Author: All of these processes may be operating in 
stone formation. Whether they occur separately or syn-
ergistically remains to be tested. Two important events 
appear to be crystals retention within the kidneys fol-
lowed by their relocation to the papillary surface. Crys-
tals may be retained either by forming large aggregates 
which occlude the ducts or by attaching to "injured" epi-
thelial cells and then aggregating with other crystals. 
Crystal aggregates then ulcerate to the epithelial surface. 
R.P. Holmes: Are you proposing that the ducts of Bel-
lini are important sites for stone formation in humans 
following outgrowth from crystal agglomerates trapped 
within the ducts? 
Author: Renal papilla and ducts of Bellini are generally 
regarded as a major site for stone formation in humans. 
The rat model has simply shown that chronic low grade 
hyperoxaluria can induce stones at the renal papilla indi-
cating that chronic low grade hyperoxaluria may also be 
the cause of similar stone formation in humans. 
A. Hesse: Most of the crystals which are taken up into 
the renal cells or into the interstitium will disappear with 
time. Do you have any idea what mechanism is respon-
sible for this phenomenon? How do they disappear? 
Author: Epithelial cells with the crystals they endo-
cytosed may be dislodged and released into the urine. 
Crystals in the interstitium probably invoke an inflam-
matory response and are dealt with by macrophages. 
We have seen macrophage s associated with interstitial 
calcium oxalate crystals. A study by Anderson and 
McDonald (1946) also showed macrophages in associa-
tion with calcific deposits in papillary interstitium of 
human kidneys . 
A. Hesse: If crystal endocytosis is a defensive mecha-
nism in the prevention of stone formation, how is it con-
trolled? Is it a defect in stone forming patients or only 
overtaxed. 
Author: Recent studies of Lieske et al . (1994) have 
shown that crystal endocytosis by renal epithelial cells is 
mediated by many anions , including glycosaminogly-
cans, nephrocalcin and citrate. Perhaps, stone patients 
have a defect in production of such molecules . 
Y. Nakagawa: How do rats form kidney stones in this 
model once becoming hyperoxaluric? Do rats consume 
inhibitors over the rate of production of inhibitors? Do 
the conditions creating hyperoxaluria cause production 
of abnormal inhibitors? 
Author: Both oxalate and calcium oxalate crystals are 
Calcium oxalate nephrolithiasis 
injurious to the epithelial cells (Hackett et al., 1994). 
Inhibition of calcium oxalate monohydrate seed crystals 
is decreased in renal injury. Renal injury also results in 
acceleration of calcium oxalate monohydrate nucleation 
(Finlayson et al., 1989). Thus, in hyperoxaluria-induc-
ing rat models of nephrolithiasis, kidney stones are a 
consequence of higher supersaturation, lower crystalliza-
tion inhibition and accelerated crystal nucleation. 
Whether crystallization inhibitors are defective or not 
available in sufficient quantities remains to be estab-
lished. 
R.L. Ryall: Numerous macromolecules and low molec-
ular weight inhibitors have been shown to inhibit calci-
um oxalate crystallization in synthetic crystallization 
systems. Yet, to date, no single putative inhibitor has 
been unequivocally demonstrated to have an undisputed 
physiological cause and effect association with the for-
mation of calcium oxalate stones. Do you think the in-
hibitor theory has been satisfactorily proven? Or is it 
still a truism awaiting scientific experimental verifica-
tion? 
Author: I agree. Inhibitor theory is a theory. Still, the 
major difference between idiopathic calcium oxalate 
stone formers and non-stone formers is reduced inhibito-
ry activity in the urine of stone forming patients (Robert-
son, 1976; Pak and Galasy, 1980; Bums and Finlayson, 
1983). Nature of substances and molecules responsible 
for the low inhibitory activity is, however , still not 
clear. I do not think a single inhibitor will ever be 
found responsible for this phenomenon in all the calcium 
oxalate stone formers. Crystallization involves a series 
of events which may be controlled by a variety of 
macromolecules. "Numerous macromolecules and low 
molecular weight inhibitors" which you say as having 
been shown to inhibit crystallization, may be involved in 
modulating different facets of the process of crystal-
lization and may also be indicative of body's tendency 
for redundancy. Most of us are investigating only one 
or two aspects of crystallization, focussing on only one 
or two inhibitors and not the whole process. For exam-
ple , we do not take into account interactions between 
various urinary macromolecules present in the urine. 
Here, I am reminded of an old parable about six blind 
men who want to know what an elephant is like. They 
touch different parts of his body and make their conclu-
sions. To one who feels his sturdy body, elephant is 
like a wall . To the other, who gets hold of his tusk, 
elephant is like a spear. The third, who chances upon 
elephant's ears, compares him to a fan. The fourth 
likens him to a tree trunk by grabbing hold of his 
massive legs. The fifth, who holds up to the elephant's 
tail, compares him to a rope and the sixth, who touches 
the trunk, thinks of elephant as a snake. 
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In addition, as you pointed out, most of the work on 
crystallization inhibition has been carried out in vitro in 
synthetic inorganic systems where inhibition is actually 
defined by the physical test used to observe it. Some of 
the data may not necessarily be applicable to in vivo 
conditions in the urine. That is why it is important to 
study these phenomena in animal models. 
As I indicated in the paper, promotary factors may 
also play crucial role in some stone forming patients. I 
consider higher supersaturation, renal injury and struc-
tural abnormalities of the kidneys as some of the factors 
that can promote the formation of kidney stones. 
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